Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Kerr

Showing results (241-250 of 315) with videos related to

Pageof 32
Sort By:
Journal of Diabetes Science and Technology|May 9, 2022
The Launch of the iCoDE Standard ProjectNicole Y Xu, Kevin T Nguyen, Ashley Y DuBord, et al.
Journal of Diabetes Science and Technology|October 9, 2023
NIH Fifth Artificial Pancreas Workshop 2023: Meeting Report: The Fifth Artificial Pancreas Workshop: Enabling Fully Automation, Access, and AdoptionRachel E Aaron, Tiffany Tian, Andrea M Yeung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal CancerRobert N Jorissen, Peter Gibbs, Michael Christie, et al.
Journal of Translational Medicine|February 26, 2026
Integrating trust into artificial intelligence for medicine: using diabetes as the exemplar diseaseMandy M Shao, Agatha F Scheideman, David Kerr, et al.
Cancer|October 18, 2018
A phase 1 study to assess the safety, tolerability, and pharmacokinetics of CXD101 in patients with advanced cancerToby A Eyre, Graham P Collins, Avinash Gupta, et al.
BMC Endocrine Disorders|December 15, 2012
Comparison of Optimised MDI versus Pumps with or without Sensors in Severe Hypoglycaemia (the Hypo COMPaSS trial)Stuart Little, Thomas Chadwick, Pratik Choudhary, et al.
Genome Medicine|May 26, 2017
Multilevel genomics of colorectal cancers with microsatellite instability-clinical impact of JAK1 mutations and consensus molecular subtype 1Anita Sveen, Bjarne Johannessen, Torstein Tengs, et al.
The Journal of Pathology|November 21, 2012
Use of multivariate analysis to suggest a new molecular classification of colorectal cancerEnric Domingo, Rajarajan Ramamoorthy, Dahmane Oukrif, et al.
The Journal of Pathology|December 23, 2015
HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trialsSusan D Richman, Katie Southward, Philip Chambers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2015
Analyses of 7,635 Patients with Colorectal Cancer Using Independent Training and Validation Cohorts Show That rs9929218 in CDH1 Is a Prognostic Marker of SurvivalChristopher G Smith, David Fisher, Rebecca Harris, et al.
Pageof 32

Showing results (241-250 of 315) with videos related to

Sort By:
Pageof 32
Journal of Diabetes Science and Technology|May 9, 2022
The Launch of the iCoDE Standard ProjectNicole Y Xu, Kevin T Nguyen, Ashley Y DuBord, et al.
Journal of Diabetes Science and Technology|October 9, 2023
NIH Fifth Artificial Pancreas Workshop 2023: Meeting Report: The Fifth Artificial Pancreas Workshop: Enabling Fully Automation, Access, and AdoptionRachel E Aaron, Tiffany Tian, Andrea M Yeung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal CancerRobert N Jorissen, Peter Gibbs, Michael Christie, et al.
Journal of Translational Medicine|February 26, 2026
Integrating trust into artificial intelligence for medicine: using diabetes as the exemplar diseaseMandy M Shao, Agatha F Scheideman, David Kerr, et al.
Cancer|October 18, 2018
A phase 1 study to assess the safety, tolerability, and pharmacokinetics of CXD101 in patients with advanced cancerToby A Eyre, Graham P Collins, Avinash Gupta, et al.
BMC Endocrine Disorders|December 15, 2012
Comparison of Optimised MDI versus Pumps with or without Sensors in Severe Hypoglycaemia (the Hypo COMPaSS trial)Stuart Little, Thomas Chadwick, Pratik Choudhary, et al.
Genome Medicine|May 26, 2017
Multilevel genomics of colorectal cancers with microsatellite instability-clinical impact of JAK1 mutations and consensus molecular subtype 1Anita Sveen, Bjarne Johannessen, Torstein Tengs, et al.
The Journal of Pathology|November 21, 2012
Use of multivariate analysis to suggest a new molecular classification of colorectal cancerEnric Domingo, Rajarajan Ramamoorthy, Dahmane Oukrif, et al.
The Journal of Pathology|December 23, 2015
HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trialsSusan D Richman, Katie Southward, Philip Chambers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2015
Analyses of 7,635 Patients with Colorectal Cancer Using Independent Training and Validation Cohorts Show That rs9929218 in CDH1 Is a Prognostic Marker of SurvivalChristopher G Smith, David Fisher, Rebecca Harris, et al.
Pageof 32